Daniel D Shapiro

12PUBLICATIONS
34CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Radiation therapyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 15, 2026
Biopsy Provides Actionable Information Associated with Treatment Decisions for 2-7 cm Renal Masses.

|Jan 28, 2026
Percutaneous Microwave Ablation Preserves Renal Function with Similar Long Term Oncologic Outcomes Compared to Surgery for Clinical T1 Renal Cell Carcinoma.

Daniel F Roadman, Daniel D Shapiro, Arighno Das

|Jun 26, 2025
Statins Are Not Associated with Improved Bladder Cancer Outcomes in Patients with Early-Stage Bladder Cancer Treated with BCG Immunotherapy.

Estelle Ndukwe, Paz Lotan, Michael Risk

|Nov 09, 2024
Paraneoplastic Resolution Holds Prognostic Utility in Patients with Metastatic Renal Cell Carcinoma.

Gregory Palmateer, Edouard H Nicaise, Taylor Goodstein

|Feb 10, 2024
Non-Metastatic Clear Cell Renal Cell Carcinoma Immune Cell Infiltration Heterogeneity and Prognostic Ability in Patients Following Surgery.

Daniel D Shapiro, Taja Lozar, Lingxin Cheng

|May 25, 2023
Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy.

Daniel D Shapiro, Niki Millward Zacharias, Durga N Tripathi

Pageof 2

Frequent Collaborators

3 joint publications

Justin R Gregg

3 joint publications

Edwin Jason Abel

2 joint publications

Paz Lotan

2 joint publications

Glenn O Allen